Verve Therapeutics, Inc. (VERV)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 6.15 |
| Open | 6.43 |
| Bid | 6.38 x 300 |
| Ask | 6.42 x 200 |
| Day's Range | 6.28 - 7.00 |
| 52 Week Range | 5.84 - 21.42 |
| Volume | |
| Avg. Volume | 1,317,883 |
| Market Cap | 537.945M |
| Beta (5Y Monthly) | 1.70 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
- Zacks
Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More
Disc Medicine, Inc. (IRON) and Verve Therapeutics (VERV) fall on study updates.
- Zacks
Verve (VERV) Pauses Enrollment in Cholesterol Study, Stock Falls
Verve (VERV) stops enrollment in the phase Ib study of gene therapy candidate VERVE-10 to reduce disease-driving low-density lipoprotein cholesterol due to safety issues. Stock plunges on the news.
© 2024 Yahoo. All rights reserved.